ERA-话题@MedSci

#ERA#

425篇内容 | 3158人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1738839, encodeId=4a8b1e3883905, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=J Rheumatol：OMERACT核心域集为风湿性多肌痛临床试验结果提供了依据, objectType=article, longId=108738, objectId=8570108e38cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8570108e38cb, replyNumber=0, likeNumber=102, createdTime=2018-06-19, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8570108e38cb, moduleTitle=J Rheumatol：OMERACT核心域集为风湿性多肌痛临床试验结果提供了依据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8570108e38cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738829, encodeId=01ea1e3882952, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Aliment Pharm Therap：运动过量，肠子会破, objectType=article, longId=101703, objectId=f5e7101e0384, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5e7101e0384, replyNumber=0, likeNumber=76, createdTime=2018-01-01, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5e7101e0384, moduleTitle=Aliment Pharm Therap：运动过量，肠子会破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5e7101e0384)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738849, encodeId=537c1e38849fc, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Aliment Pharm Therap：肝病患者服用β受体阻滞剂哪项心肺运动测试不受影响？, objectType=article, longId=116836, objectId=5f23116836cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f23116836cc, replyNumber=0, likeNumber=135, createdTime=2018-09-26, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f23116836cc, moduleTitle=Aliment Pharm Therap：肝病患者服用β受体阻滞剂哪项心肺运动测试不受影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f23116836cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738874, encodeId=730b1e3887485, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Aliment Pharmacol Therap：亚洲慢性基因型1丙型肝炎患者适合跟干扰素说再见吗？, objectType=article, longId=131533, objectId=a440131533eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a440131533eb, replyNumber=0, likeNumber=87, createdTime=2018-06-19, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a440131533eb, moduleTitle=Aliment Pharmacol Therap：亚洲慢性基因型1丙型肝炎患者适合跟干扰素说再见吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a440131533eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738835, encodeId=25ec1e3883574, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Pharmacotherapy：急性失代偿性心衰：多巴酚丁胺vs米力农对出院死亡率的影响, objectType=article, longId=107619, objectId=a4f110e61914, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4f110e61914, replyNumber=0, likeNumber=70, createdTime=2017-09-06, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4f110e61914, moduleTitle=Pharmacotherapy：急性失代偿性心衰：多巴酚丁胺vs米力农对出院死亡率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4f110e61914)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738870, encodeId=a0751e3887057, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Pharmacotherapy：新型直接口服抗凝剂减少治疗中断噱头还是事实？, objectType=article, longId=129090, objectId=70a91290900a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70a91290900a, replyNumber=0, likeNumber=61, createdTime=2018-07-31, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70a91290900a, moduleTitle=Pharmacotherapy：新型直接口服抗凝剂减少治疗中断噱头还是事实？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70a91290900a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738845, encodeId=7a371e388454e, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Theranostics：靶向cZNF609或可有效治疗血管功能障碍, objectType=article, longId=115236, objectId=5c94115236f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c94115236f7, replyNumber=0, likeNumber=41, createdTime=2018-07-12, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c94115236f7, moduleTitle=Theranostics：靶向cZNF609或可有效治疗血管功能障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c94115236f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738866, encodeId=33c21e388663e, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Sci Rep：一种基于色酮的STAT3抑制剂Erasin，在厄洛替尼耐药的肺癌细胞中诱导凋亡, objectType=article, longId=125082, objectId=eead1250826d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eead1250826d, replyNumber=0, likeNumber=45, createdTime=2018-03-02, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eead1250826d, moduleTitle=Sci Rep：一种基于色酮的STAT3抑制剂Erasin，在厄洛替尼耐药的肺癌细胞中诱导凋亡, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eead1250826d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738882, encodeId=3f551e3888280, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Theranostics：开发出胎盘靶向药物投递新工具, objectType=article, longId=135006, objectId=6d4c135006e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d4c135006e1, replyNumber=0, likeNumber=148, createdTime=2018-05-19, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d4c135006e1, moduleTitle=Theranostics：开发出胎盘靶向药物投递新工具, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d4c135006e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738871, encodeId=50921e38871b8, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Pharmacotherapy：AMI住院的老年患者接受ACEIs或ARBs治疗后及时停用至关重要, objectType=article, longId=129093, objectId=8b8c129093a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b8c129093a7, replyNumber=0, likeNumber=48, createdTime=2018-11-16, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b8c129093a7, moduleTitle=Pharmacotherapy：AMI住院的老年患者接受ACEIs或ARBs治疗后及时停用至关重要, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b8c129093a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738853, encodeId=41811e38853f7, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=【AHA 2017】ACCELERATOR-2研究：STEMI区域化医疗系统的优化, objectType=article, longId=120699, objectId=0ade1206998f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ade1206998f, replyNumber=0, likeNumber=76, createdTime=2018-08-15, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ade1206998f, moduleTitle=【AHA 2017】ACCELERATOR-2研究：STEMI区域化医疗系统的优化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ade1206998f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738859, encodeId=fc261e38859bb, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Cytotherapy：间充质基质细胞释放的胞外囊泡可用于治疗成骨不全患者, objectType=article, longId=122105, objectId=c69d1221055e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c69d1221055e, replyNumber=0, likeNumber=62, createdTime=2018-09-10, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c69d1221055e, moduleTitle=Cytotherapy：间充质基质细胞释放的胞外囊泡可用于治疗成骨不全患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c69d1221055e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738827, encodeId=fb271e388273d, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Aptuit宣布与Regulus Therapeutics达成战略供应商协议, objectType=article, longId=101145, objectId=714d10114563, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=714d10114563, replyNumber=0, likeNumber=58, createdTime=2018-04-15, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=714d10114563, moduleTitle=Aptuit宣布与Regulus Therapeutics达成战略供应商协议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=714d10114563)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738878, encodeId=905d1e38878cd, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Immunotherapy：单磷酰脂质A辅助的特异性免疫治疗在患有花粉过敏患者中的长期影响研究, objectType=article, longId=133424, objectId=35df1334248e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35df1334248e, replyNumber=0, likeNumber=59, createdTime=2018-05-15, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35df1334248e, moduleTitle=Immunotherapy：单磷酰脂质A辅助的特异性免疫治疗在患有花粉过敏患者中的长期影响研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35df1334248e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738876, encodeId=79a11e388769f, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Aliment Pharm Therap:中度至重度溃疡性结肠炎：托法替布vs生物制剂, objectType=article, longId=131750, objectId=cb93131e509e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb93131e509e, replyNumber=0, likeNumber=94, createdTime=2018-12-01, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb93131e509e, moduleTitle=Aliment Pharm Therap:中度至重度溃疡性结肠炎：托法替布vs生物制剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb93131e509e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738868, encodeId=0ebb1e3886856, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Aliment Pharm Therap：肝硬化腹水患者停用或再使用β-受体阻滞剂对死亡率有何影响？, objectType=article, longId=127424, objectId=2c7312e424ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2c7312e424ad, replyNumber=0, likeNumber=102, createdTime=2018-02-23, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2c7312e424ad, moduleTitle=Aliment Pharm Therap：肝硬化腹水患者停用或再使用β-受体阻滞剂对死亡率有何影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2c7312e424ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738843, encodeId=ef671e388437d, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=首例接受瓦里安HyperArc高精度放射治疗的患者于意大利接受治疗, objectType=article, longId=112590, objectId=feea1125905e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=feea1125905e, replyNumber=0, likeNumber=70, createdTime=2018-06-10, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=feea1125905e, moduleTitle=首例接受瓦里安HyperArc高精度放射治疗的患者于意大利接受治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=feea1125905e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738818, encodeId=81811e3881893, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Theranostics：同济大学黄琦、葛步军课题组发现调控结直肠癌的全新微小RNA, objectType=article, longId=97866, objectId=bc929e86626, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc929e86626, replyNumber=0, likeNumber=112, createdTime=2017-10-12, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc929e86626, moduleTitle=Theranostics：同济大学黄琦、葛步军课题组发现调控结直肠癌的全新微小RNA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc929e86626)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738846, encodeId=e6231e3884653, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Pharmacotherapy：ACS：三种口服抗血小板药物治疗的临床结局, objectType=article, longId=115969, objectId=c83c1159696b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c83c1159696b, replyNumber=0, likeNumber=108, createdTime=2018-06-03, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c83c1159696b, moduleTitle=Pharmacotherapy：ACS：三种口服抗血小板药物治疗的临床结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c83c1159696b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1738851, encodeId=a92e1e388517b, content=<a href='/topic/show?id=6e566913df' target=_blank style='color:#2F92EE;'>#ERA#</a>, objectTitle=Theranostics：干细胞治疗有望改善糖尿病人的外周动脉病变, objectType=article, longId=120343, objectId=c719120343b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c719120343b5, replyNumber=0, likeNumber=80, createdTime=2018-05-21, rootId=0, userName=124988c7m106暂无昵称, userId=e36234488643, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c719120343b5, moduleTitle=Theranostics：干细胞治疗有望改善糖尿病人的外周动脉病变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c719120343b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ERA

2020-05-29

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

J Rheumatol：OMERACT核心域集为风湿性多肌痛临床试验结果提供了依据

2018-06-19

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Aliment Pharm Therap：运动过量，肠子会破

2018-01-01

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Aliment Pharm Therap：肝病患者服用β受体阻滞剂哪项心肺运动测试不受影响？

2018-09-26

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Aliment Pharmacol Therap：亚洲慢性基因型1丙型肝炎患者适合跟干扰素说再见吗？

2018-06-19

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Pharmacotherapy：急性失代偿性心衰：多巴酚丁胺vs米力农对出院死亡率的影响

2017-09-06

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Pharmacotherapy：新型直接口服抗凝剂减少治疗中断噱头还是事实？

2018-07-31

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Theranostics：靶向cZNF609或可有效治疗血管功能障碍

2018-07-12

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Sci Rep：一种基于色酮的STAT3抑制剂Erasin，在厄洛替尼耐药的肺癌细胞中诱导凋亡

2018-03-02

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Theranostics：开发出胎盘靶向药物投递新工具

2018-05-19

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Pharmacotherapy：AMI住院的老年患者接受ACEIs或ARBs治疗后及时停用至关重要

2018-11-16

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

【AHA 2017】ACCELERATOR-2研究：STEMI区域化医疗系统的优化

2018-08-15

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Cytotherapy：间充质基质细胞释放的胞外囊泡可用于治疗成骨不全患者

2018-09-10

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Aptuit宣布与Regulus Therapeutics达成战略供应商协议

2018-04-15

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Immunotherapy：单磷酰脂质A辅助的特异性免疫治疗在患有花粉过敏患者中的长期影响研究

2018-05-15

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Aliment Pharm Therap:中度至重度溃疡性结肠炎：托法替布vs生物制剂

2018-12-01

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Aliment Pharm Therap：肝硬化腹水患者停用或再使用β-受体阻滞剂对死亡率有何影响？

2018-02-23

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

首例接受瓦里安HyperArc高精度放射治疗的患者于意大利接受治疗

2018-06-10

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Theranostics：同济大学黄琦、葛步军课题组发现调控结直肠癌的全新微小RNA

2017-10-12

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Pharmacotherapy：ACS：三种口服抗血小板药物治疗的临床结局

2018-06-03

124988c7m106暂无昵称 (审核中...)

前往app查看评论内容

#ERA#

Theranostics：干细胞治疗有望改善糖尿病人的外周动脉病变

2018-05-21

科室
- - 订阅+
  - 更多科室
工具
服务